CSIMarket
 
Marrone Bio Innovations Inc   (MBII)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 182
 Employees 97
 Revenues (TTM) (Millions $) 44
 Net Income (TTM) (Millions $) -21
 Cash Flow (TTM) (Millions $) -10
 Capital Exp. (TTM) (Millions $) 1

Marrone Bio Innovations Inc
We make bio-based pest management and plant health products. Bio-based products are comprised of naturally occurring microorganisms, such as bacteria and fungi, and plant extracts. Our current products target the major markets that use conventional chemical pesticides, including certain agricultural and water markets, where our bio-based products are used as alternatives for, or mixed with, conventional chemical products. We also target new markets for which (i) there are no available conventional chemical pesticides or (ii) the use of conventional chemical pesticides may not be desirable or permissible either because of health and environmental concerns (including for organically certified crops) or because the development of pest resistance has reduced the efficacy of conventional chemical pesticides. All of our current products are approved by the United States Environmental Protection Agency (“EPA”) and registered as “biopesticides.” We expect our future products will include plant health products qualified as “biostimulants,” which may require state registrations, but do not require EPA registration. We believe our current portfolio of products and our pipeline address the growing global demand for effective, efficient and environmentally responsible products to control pests, increase crop yields and reduce crop stress.


   Company Address: 7780-420 Brier Creek Parkway Raleigh 27617 NC
   Company Phone Number: 750-2800   Stock Exchange / Ticker: NASDAQ MBII
   


Customers Net Income fell by MBII's Customers Net Profit Margin fell to

-9.44 %

11.33 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AVD        18.89% 
CF        0.67% 
CGA        2.33% 
MHDG        2.33% 
MOS        2.74% 
SANW        0.38% 
• View Complete Report
   



Golden Growers Cooperative

Golden Growers Cooperative Faces Turbulent Times with 32% Drop in Revenue for Q4 2023

Golden Growers Cooperative, an agricultural production company, reported its earnings for the fourth quarter of 2023, and the results were not as positive as expected. The company announced a drop in earnings per share of -32.43% from $0.12 per share to $0.08 per share compared to the same quarter a year ago.
Additionally, the earnings per share surged by 14.29% from $0.07 per share from the previous financial reporting period. This fluctuation in earnings per share suggests that the company's performance has been volatile and unpredictable in recent quarters.

Icl Group Ltd

Challenges and Contractions: ICL Group Ltd Faces Struggles in Fourth Quarter Revenue Report

ICL Group Ltd, a leading global specialty minerals company, has recently released its financial results for the most recent fiscal period, and they paint a bleak picture for the company's future. The revenue contraction of -24.753% has caused a significant deterioration in the bottom-line, with a decrease of -70.06% in net income.
Comparing the recent numbers to the previous year, ICL recorded revenue of $7.54 billion, a significant decline from $10.02 billion. This decrease in revenue is a clear indication that the company is facing challenges in generating sales and attracting customers. Additionally, earnings per share (EPS) fell from $1.67 to $0.50, a decline of -70.06%.

Archer Daniels Midland Co

Archer Daniels Midland Co Sees Significant Decline in Revenue and Income in Fourth Quarter

In the fourth quarter of 2023, Archer Daniels Midland Co (ADM) reported a decline in both top and bottom-line performance. The company's income per share dropped by 41.83% and revenue decreased by 11.415% year on year. The revenue for the quarter amounted to $22.98 billion, compared to $25.94 billion in the same period the previous year. Earnings per share (EPS) also declined from $1.84 to $1.07.
Compared to previous periods, income per share fell by 29.73% from $1.52 and revenue increased by 5.914% from $21.70 billion. Earnings for the fiscal period ending December 31, 2023, totaled $542 million, a 47.07% decrease from $1,024 million in the corresponding period a year earlier.

The Davey Tree Expert Company

DVTX Reports Impressive Financial Growth Despite Decrease in Revenue

DVTX, a leading agricultural production company, recently released its financial report for the fiscal year ending December 31, 2023, and the numbers are impressive. Despite a decrease in revenue and income compared to the previous year, the company still managed to achieve substantial growth.
In the report, DVTX announced a remarkable income elevation of 23.28% to $0.29 per share, showcasing its ability to drive profitability even in challenging times. This increase in earnings per share demonstrates the company's commitment to delivering value to its shareholders.

Calavo Growers Inc

Calavo Growers Inc Suffers Major Losses in First Quarter of 2024

The stock market is always a battlefield of highs and lows, with companies constantly striving to show positive financial results to keep their investors happy. However, not every company is able to meet these expectations, as evidenced by the recent news surrounding Calavo Growers Inc.
Calavo Growers, a leading player in the agricultural industry, recently reported its financial results for the fiscal first quarter ending January 31, 2024. The numbers paint a grim picture, with the company facing a net loss of $-6.257 million for this period, compared to $-2.795 million in the prior year. This substantial increase in losses has raised concerns among investors and analysts, prompting the company to delay the release of its Fourth Quarter and Fiscal Year 2023 financial results.






 

Marrone Bio Innovations Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com